[Protective effect of placental lysozyme on experimental infections in mice induced by Clostridium tetani, Staphylococcus aureus and Diplococcus pneumoniae].
D000818:Animals; D003015:Clostridium Infections / Q000188:drug therapy*; D003017:Clostridium tetani / Q000187:drug effects*; D004357:Drug Synergism; D005260:Female; D008297:Male; D051379:Mice; D008826:Microbial Sensitivity Tests; D009113:Muramidase / Q000494:pharmacology / Q000627:therapeutic use*; D010406:Penicillins / Q000627:therapeutic use; D010920:Placenta / Q000201:enzymology; D011008:Pneumococcal Infections / Q000188:drug therapy*; D011247:Pregnancy; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013210:Staphylococcus / Q000187:drug effects*; D013296:Streptococcus pneumoniae / Q000187:drug effects*
D010406:Penicillins; D009113:Muramidase